Home > Income Statement > BETA DRUGS

BETA DRUGS
Operating Profit

    Back to Income Statement
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Operating Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Operating Profit (Excl OI) ₹75 Cr₹5,999,757 Cr₹0.00 Cr₹43 Cr₹25 Cr

What is the latest Operating Profit of BETA DRUGS ?

The latest Operating Profit ratio of BETA DRUGS is ₹75 Cr based on Mar2026 Consolidated results.
Year Operating Profit
Mar2026₹75 Cr
Mar2025₹5,999,757 Cr
Mar2024₹0.00 Cr
Mar2023₹43 Cr
Mar2022₹25 Cr

How is Operating Profit of BETA DRUGS Trending?

Years Operating Profit % Change
Mar2026 ₹75 Cr
-100.00
Mar2025 ₹5,999,757 Cr
599,975,652,400.00
Mar2024 ₹0.00 Cr
-100.00
Mar2023 ₹43 Cr
72.57
Mar2022 ₹25 Cr -

Compare Operating Profit of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,004.5 Cr 1.7% -9.3% -0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr 5.2% 4.3% 8% Stock Analytics
DIVIS LABORATORIES ₹273,565.0 Cr 3.6% 7.6% 50.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,332.0 Cr 3.4% 0.7% 32.6% Stock Analytics
DR REDDYS LABORATORIES ₹114,532.0 Cr 2.3% 14% 13.6% Stock Analytics
CIPLA ₹113,831.0 Cr 2% 6% -6.7% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

1.7%

-9.3%

-0.8%

SENSEX

8.8%

10.9%

-4%


You may also like the below Video Courses